Khiron Life Sciences (Khiron Life Sciences) Total Liabilities : $8.51 Mil (As of Sep. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Khiron Life Sciences Total Liabilities?

Khiron Life Sciences's Total Liabilities for the quarter that ended in Sep. 2022 was $8.51 Mil.

Khiron Life Sciences's quarterly Total Liabilities declined from Mar. 2022 ($9.74 Mil) to Jun. 2022 ($8.09 Mil) but then increased from Jun. 2022 ($8.09 Mil) to Sep. 2022 ($8.51 Mil).

Khiron Life Sciences's annual Total Liabilities declined from Dec. 2019 ($9.02 Mil) to Dec. 2020 ($7.77 Mil) and declined from Dec. 2020 ($7.77 Mil) to Dec. 2021 ($6.99 Mil).

Khiron Life Sciences Total Liabilities Historical Data

The historical data trend for Khiron Life Sciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Khiron Life Sciences Total Liabilities Chart

Khiron Life Sciences Annual Data

Trend

May12

May13

May14

May15

May16

May17

Dec18

Dec19

Dec20

Dec21

Total Liabilities

Get a 7-Day Free Trial

0.09

11.02

9.02

7.77

6.99

Khiron Life Sciences Quarterly Data
	Nov17	Feb18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Total Liabilities	Get a 7-Day Free Trial															9.00	6.99	9.74	8.09	8.51

Khiron Life Sciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Khiron Life Sciences's Total Liabilities for the fiscal year that ended in Dec. 2021 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	6.029	+	(0.551	+	4.9960036108132E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0.408	+	0)
	=	6.99

Total Liabilities	=	Total Assets (A: Dec. 2021 )	-	Total Equity (A: Dec. 2021 )
	=	33.027	-	26.038
	=	6.99

Khiron Life Sciences's Total Liabilities for the quarter that ended in Sep. 2022 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	7.205	+	(1.003	+	-8.3266726846887E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0.3	+	0)
	=	8.51

Total Liabilities	=	Total Assets (Q: Sep. 2022 )	-	Total Equity (Q: Sep. 2022 )
	=	28.827	-	20.319
	=	8.51

Khiron Life Sciences Total Liabilities Related Terms

Thank you for viewing the detailed overview of Khiron Life Sciences's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Khiron Life Sciences (Khiron Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Khiron Life Sciences Corp (OTCPK:KHRWF) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

2300 - 500 Burrard Street, Vancouver, BC, CAN, V6C 2B5

Website

https://www.khiron.ca

Khiron Life Sciences Corp is a vertically integrated medical company with core operations in Latin America and Europe, The company's platform leverages medical health clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific, product innovation, and cannabis operations expertise to drive prescriptions and brand loyalty with patients worldwide. The company has a presence in Mexico, Peru, Germany, the United Kingdom, and Brazil.